Renaud Ronald C JR
SEC-identified person · CIK 1354434 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Upstream Bio, Inc. UPB | Director | filed 2024 - 2026 |
| Kailera Therapeutics, Inc. KLRA | Director · CEO & President | filed 2026 - 2026 |
| Cerevel Therapeutics Holdings, Inc. CERF | Director · President & CEO | filed 2023 - 2024 |
| Atara Biotherapeutics, Inc. ATRA | Director | filed 2020 - 2022 |
| Imagenebio, Inc. IMA | Director | filed 2021 - 2022 |
| Translate Bio, Inc. TBIO | Director · See Remarks | filed 2018 - 2021 |
| Chimerix INC CRMX | Director | filed 2014 - 2019 |
| Akebia Therapeutics, Inc. AKBA | Director | filed 2014 - 2018 |
| PTC Therapeutics, INC. PTCT | Director | filed 2014 - 2017 |
| Idenix Pharmaceuticals INC IDIX | Director · President & CEO | filed 2007 - 2014 |
| Keryx Biopharmaceuticals INC KERX | SVP, CFO, Treasurer, Secretary | filed 2006 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.